LATEST MANUSCRIPTS IN Journal of Comparative Effectiveness Research
Jeffrey Frankel, David Staskin, Susann Varano, Diane K Newman, Steven G Gregg, Janet Owens-Grillo. Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?Journal of comparative effectiveness research. 2023, 12 (9): CER
David Staskin, Jeffrey Frankel, Steven G Gregg, Susann Varano, Janet Owens-Grillo. Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study.Journal of comparative effectiveness research. 2023, 12 (9): CER
Virender Bhan, Fraser Clift, Moogeh Baharnoori, Kimberly Thomas, Barkha P Patel, François Blanchette, Nicholas Adlard, Umakanth Vudumula, Kapil Gudala, Nikkita Dutta, Daniel Grima, Soukaïna Mouallif, Fatine Farhane. Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada.Journal of comparative effectiveness research. 2023, 12 (9): e220175
Jose Osorio, Sonia Maccioni, Reecha Sharma, Leena Patel, Paul Spin, Andrea Natale. QDOT MICRO™ versus THERMOCOOL SMARTTOUCH™ and THERMOCOOL SMARTTOUCH Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation.Journal of comparative effectiveness research. 2023, 12 (9): e230005
Teri J Mauch, Michael R Chladek, Spero Cataland, Shruti Chaturvedi, Bradley P Dixon, Katherine Garlo, Christoph Gasteyger, Anuja Java, Jorge Leguizamo, Lucy Lloyd-Price, Tan P Pham, Tara Symonds, Ioannis Tomazos, Yan Wang. Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome.Journal of comparative effectiveness research. 2023, 12 (9): e230036
Aaron T Gerds, Claudia Castro, Frank Snopek, Megan M Flynn, Alexandra G Ellis, Meredith Manning, Ray Urbanski. Cost-effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera.Journal of comparative effectiveness research. 2023, 12 (9): e230066
Joel Iff, Yi Zhong, Edward Tuttle, Deepshekhar Gupta, Xander Paul, Erik Henricson. Real-world evidence of eteplirsen treatment effects in patients with Duchenne muscular dystrophy in the USA.Journal of comparative effectiveness research. 2023, 12 (9): e230086
Sreeram V Ramagopalan, Catrin Treharne, Jonathan Pearson-Stuttard, Vivek Subbiah. For what it's worth: the complex area of medicine value assessment.Journal of comparative effectiveness research. 2023, 12 (9): e230120
Marissa Betts, Kyle Fahrbach, Binod Neupane, Mahmoud Slim, Maria Pia Sormani, Gary Cutter, Thomas Pa Debray, Marvin Rock. Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis.Journal of comparative effectiveness research. 2023, 12 (8): e220132
Jie He, Yuanyuan Gao, Ge Bai, Jie Wang, Yongshun Sun. Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis.Journal of comparative effectiveness research. 2023, 12 (8): e220165
Svenja Petersohn, Bradley McGregor, Sven L Klijn, Jessica R May, Flavia Ejzykowicz, Murat Kurt, Matthew Dyer, Bill Malcolm, Sébastien Branchoux, Katharina Nickel, Saby George, Sonja Kroep. Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma.Journal of comparative effectiveness research. 2023, 12 (8): e230004
Josep Comín Colet, Antoni Sicras Mainar, Joel Salazar-Mendiguchía, María Isabel Del Campo Alonso, Ainara Echeto, David Vilanova Larena, Olga Delgado Sánchez. Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol.Journal of comparative effectiveness research. 2023, 12 (8): e230007
Petra Stazić, Diana Jurić, Antonela Turić, Antonio Šošić, Ana Marušić, Marija Roguljić. Reporting characteristics of nonsurgical periodontal therapy trials registered in ClinicalTrials.gov: an observational study.Journal of comparative effectiveness research. 2023, 12 (8): e230058
Jennifer Ken-Opurum, Sesha Ss Srinivas, Seojin Park, Scott Charland, Andrew Revel, Ronald Preblick. Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation.Journal of comparative effectiveness research. 2023, 12 (8): e230065
Ayman Al-Hendy, Andrea S Lukes, Roberta Venturella, Claudio Villarroel, Laura McKain, Yulan Li, Rachel B Wagman, Elizabeth A Stewart. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.Journal of comparative effectiveness research. 2023, 12 (8): e230069